Middle East and Africa Point-of-Care Diagnostics Market Industry Analysis | Persistence Market Research

The Middle East and Africa (MEA) point-of-care diagnostics market is rapidly evolving, shaped by an increasing burden of infectious and chronic diseases, a surge in healthcare modernization, and innovations in diagnostic technologies. As per Persistence Market Research, the market is projected to grow from US$ 2.7 Bn in 2024 to US$ 6.1 Bn by 2031, expanding at a robust CAGR of 12.3% during the forecast period.

Leading this transformation are technological advancements and growing government investments aimed at decentralizing diagnostics and improving accessibility. The infectious disease testing segment dominates product demand due to high incidence rates and ongoing public health initiatives. Geographically, Saudi Arabia stands out with a commanding 30% market share in 2024, driven by significant healthcare reforms and investments in digital health technologies.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/34917

Key Highlights from the Report

• Kingdom of Saudi Arabia leads with a 30% market share due to healthcare modernization initiatives.
• Prescription-based diagnostics account for 65% of market share amid growing demand for accurate testing.
• Infectious disease testing is the leading product segment, holding 30.9% share in 2024.
• AI and machine learning integration in diagnostic tools creates new innovation opportunities.
• Development of rapid tests for emerging diseases fuels long-term market expansion.
• Preventive healthcare adoption boosts point-of-care diagnostics penetration in wellness sectors.

Market Segmentation

The MEA point-of-care diagnostics market is segmented based on product types such as infectious disease testing, glucose monitoring, cardiometabolic monitoring, and hematology testing. Infectious disease testing holds the largest share, thanks to governmental focus on pandemic preparedness and outbreak response. Innovations in molecular testing and the rising availability of portable diagnostics are also contributing factors to the dominance of this segment.

In terms of end users, the market is categorized into hospitals, homecare settings, diagnostic laboratories, and ambulatory care centers. Hospitals remain the primary users due to their ability to integrate POC diagnostics into comprehensive care pathways. However, homecare and remote clinics are witnessing the fastest growth as demand rises for decentralized and on-the-spot diagnostics, especially in underserved areas.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/middle-east-africa-point-of-care-diagnostics-market.asp

Regional Insights

In the Middle East, Saudi Arabia is the dominant market owing to its progressive national healthcare strategies and partnerships with global diagnostic players. The government's commitment to modernizing health infrastructure and incorporating telehealth and AI technologies into clinical care strongly supports the demand for POC diagnostics.

Across Africa, countries like South Africa, Kenya, and Nigeria are gradually adopting POC solutions. With limited access to centralized labs and high disease burden, POC diagnostics serve as essential tools. Ongoing investments in mobile health and donor-funded public health programs are further driving growth in these regions.

Market Drivers
Rising Prevalence of Infectious and Chronic Diseases

One of the primary drivers of market growth is the alarming rise in chronic and infectious diseases across the region. Diabetes, for instance, is significantly impacting populations, particularly in the Gulf states. According to the International Diabetes Federation, 12.3% of UAE's population had diabetes in 2021, with projections estimating a rise to 21.4% by 2030. A staggering 64% of cases remain undiagnosed, underlining the urgent need for early diagnostic interventions. Point-of-care diagnostics play a pivotal role in providing rapid, accessible, and efficient testing, especially in areas with limited healthcare infrastructure.

Demand for Rapid and Accurate Diagnostics

As healthcare systems in the MEA region modernize, the need for swift and accurate diagnostic tools becomes paramount. Point-of-care diagnostics bridge critical gaps by offering real-time results at the bedside or in outpatient settings. These diagnostics significantly enhance clinical decision-making and treatment timelines, particularly in emergency and infectious disease settings. The integration of advanced technologies such as AI and machine learning is also amplifying diagnostic precision, making POC tools more reliable and widely adopted.

Market Restraints
Low Healthcare Spending in Several Countries

Despite rapid development in Gulf nations, several African and lower-income Middle Eastern countries struggle with constrained healthcare budgets. The high initial costs of point-of-care devices, coupled with limited infrastructure for support and maintenance, remain substantial hurdles. Furthermore, inadequate reimbursement frameworks and lack of awareness restrict the widespread adoption of advanced diagnostic tools. These limitations are especially significant in rural areas where healthcare delivery is already under strain.

Market Opportunities
Expansion in Remote and Underserved Regions

A major opportunity lies in the deployment of point-of-care diagnostics in remote and underserved areas. Inaccessibility to centralized testing labs often leads to delayed diagnosis and treatment. Portable POC devices offer timely, affordable solutions, especially for managing infectious diseases like HIV, TB, and COVID-19. Governments and global health agencies are actively investing in POC infrastructure to strengthen rural healthcare delivery.

Telemedicine Integration and Mobile Health Innovations

The convergence of POC diagnostics with telemedicine and mobile health technologies is another lucrative growth avenue. Smartphone-based diagnostics, cloud-based reporting, and remote patient monitoring are transforming how care is delivered. With rising internet penetration and growing familiarity with mobile platforms, these integrated solutions are being increasingly embraced, especially in younger populations and in urbanized regions. This trend presents significant potential for companies to broaden their service offerings while improving patient engagement and outcomes.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/34917

Reasons to Buy the Report

• Gain a comprehensive understanding of market size, CAGR, and growth trends through 2031.
• Stay ahead of competition with insights on leading segments, including infectious disease diagnostics and prescription-based testing.
• Leverage in-depth regional analysis highlighting growth drivers in Saudi Arabia and emerging African markets.
• Access valuable forecasts, technological trends, and evolving consumer behaviors.
• Identify key investment opportunities in AI-integrated POC diagnostics and telemedicine.

Frequently Asked Questions (FAQs)

• How big is the Middle East and Africa point-of-care diagnostics market in 2024?
• What is the projected growth rate of the point-of-care diagnostics market through 2031?
• Which region is estimated to dominate the industry through the forecast period?
• What is the market forecast for the Middle East and Africa point-of-care diagnostics market by 2032?
• Who are the key players in the global market for point-of-care diagnostics?

Company Insights

The Middle East and Africa point-of-care diagnostics market comprises several key players offering advanced testing solutions and diagnostics platforms:

• Abbott
• F. Hoffmann-La Roche Ltd
• Danaher Corporation
• BD (Becton Dickinson)
• QIAGEN
• BIOMÉRIEUX
• Nova Biomedical
• Siemens Healthcare Private Limited
• Trividia Health, Inc.
• Werfen

Recent Developments

• In January 2024, QIAGEN opened its new regional headquarters in Riyadh, Saudi Arabia, and signed an MoU with the Saudi Ministry of Health to support public health initiatives.
• In September 2024, amplifAI health partnered with USATherm to enhance thermal imaging capabilities in disease monitoring, combining telehealth tools with advanced diagnostic technologies.

Conclusion

The Middle East and Africa point-of-care diagnostics market is on a transformative growth path, powered by rising healthcare needs, chronic disease burdens, and a shift toward patient-centric diagnostic models. Innovations in digital health, growing public and private investments, and a favorable policy environment are creating unprecedented opportunities in both urban and rural areas.

With key countries like Saudi Arabia leading the charge, and technologies like AI and mobile diagnostics rapidly evolving, the future of this market is promising. Companies that capitalize on these emerging trends and align with the regional healthcare priorities are poised to lead the next wave of diagnostic revolution in MEA.

As highlighted by Persistence Market Research, stakeholders-from diagnostic device manufacturers to healthcare policymakers-must act now to tap into this high-growth market and contribute to building more resilient, accessible, and efficient healthcare systems in the region.

Read More Related Reports:

Nap Pod Market https://www.persistencemarketresearch.com/market-research/nap-pod-market.asp
Postpartum Depression Therapeutics Market https://www.persistencemarketresearch.com/market-research/postpartum-depression-therapeutics-market.asp
Glutathione Market https://www.persistencemarketresearch.com/market-research/glutathione-market.asp
Induced Pluripotent Stem Cells Market https://www.persistencemarketresearch.com/market-research/induced-pluripotent-stem-cells-market.asp
Lichen Sclerosus Treatment Market https://www.persistencemarketresearch.com/market-research/lichen-sclerosus-treatment-market.asp

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.